Live Breaking News & Updates on எடிசன் குழு|Page 16
Stay updated with breaking news from எடிசன் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MeaTech Reports 2020 Financial Results USA - English Highlights · Commenced trading on TASE in January 2020 and Nasdaq in March 2021: first publicly traded cultured meat company, developing sustainable and ethical food technologies. · Finalized acquisition of Peace of Meat BV ( POM ), a pioneering Belgian developer of cultured avian meat technologies, in February 2021. · In November 2020, successfully bio-printed an edible cultured beef fat structure grown and developed from stem cells. · 2020 year-end cash position was $13.5 million ($8.5 million pro-forma to POM acquisition) with further $28 million raised as part of the Nasdaq listing, bringing current cash position to $33.5 million. News provided by Share this article Share this article ....
Kazia Therapeutics valuation lifts off the back of in-licensing of EVT901 drug: Edison Group Much of Kazia’s operational capacity has opened up with the inclusion of paxalisib in the GBM AGILE study, and the company believes that it can dedicate significant resources to the EVT801 program. The report also flagged a peak penetration of 15% and with the expectation of initial commercialisation in 2028. Kazia Therapeutics Ltd’s (ASX:KZA) (FRA:NV9) (NASDAQ:KZIA) valuation has increased to A$346 million or A$2.68 per share from A$301 million or A$2.32 per share following the company’s in-licensing of EVT801, a novel small molecule inhibitor of VEGFR3, from Evotec SE (FRA:EVT) (OTCMKTS:EVTCY) ....
MeaTech 3D Announces Initiation of Food Technology Development Activities in Europe prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Kazia Therapeutics Ltd valuation lifts off the back of in-licensing of EVT901 drug: Edison Group proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Published: Apr 19, 2021 Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021 Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software within digital health and precision medicine platform at multiple healthcare institutions GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) OpGen, Inc. (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health (“DOH”) to develop a state-of-the-art solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide is being extended beyond the second-year expansion phase by another six months through September 30, 2021. Having successfully achieved all of the milestones of the first and second year phases for the development of an infectious disease digital health and precision medicine platform that connects health ....